MUCHMontreal, Quebec, Canada
Disclosure information not submitted.
Paper 52 - REAL-WORD EXPERIENCE OF SORAFENIB AND PAZOPANIB IN PATIENTS WITH DESMOID TUMORS: A CANSARCC STUDY
Friday, November 3, 20232:30 PM – 4:00 PM